National People's Congress representative and Chairman of Cowin Biotech, Wang Chunxiang: Suggests incorporating the monitoring of antimicrobial resistance of pathogenic microorganisms into the national public health system

Wang Chunxiang, a representative of the National People's Congress and chairman of Cowin Biotech, suggested incorporating the monitoring of pathogenic microorganisms' drug resistance into the national public health system to strengthen the health defense line for all citizens. "With the widespread use of antibiotics, the issue of drug resistance in pathogenic microorganisms is becoming increasingly severe, posing a threat to clinical treatment and public health safety," Wang Chunxiang emphasized. Establishing a comprehensive monitoring system and keeping abreast of drug resistance dynamics in a timely manner is crucial for the rational use of antibiotics and safeguarding public health. She stated that under the strategic framework of comprehensively promoting the upgrade of the life and health industry, Cowin Biotech will focus on transforming from a technology and product supplier to a full-cycle health management service provider covering "prevention—detection—treatment." "From intelligent analysis of pathogen identification and drug resistance genes to leading global early screening technology for tumors, Cowin Biotech plans to build a comprehensive defense line for the digestive and respiratory tracts, providing technological support for national cancer prevention and control and public health management, creating an internationally leading integrated platform for precision medical solutions."